-
Estimating the Eligible Population for Anti-Amyloid Therapy in Finland
Sep 9, 2025, 16:22 PM -
Where Is AI in Evidence Synthesis for NICE HTA Submissions?
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Eplerenone For the Management of Heart Failure With Reduced Ejection Fraction (HFrEF) in Italy
Sep 9, 2025, 16:22 PM -
Tropical Virus in France: Dengue Cases on the Rise
Sep 9, 2025, 16:22 PM -
Quantifying the Fiscal Benefits of Obesity Prevalence Reduction in China: A Public Economic Perspective
Sep 9, 2025, 16:22 PM -
Early Life Hypoglycemia and Neurological Sequalae in Children With Congenital Hyperinsulinism
Sep 9, 2025, 16:22 PM -
Public Health Impact of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for Prevention of Respiratory Syncytial Virus Illness Among High-Risk Adults Aged 18-59 Years in Germany
Sep 9, 2025, 16:22 PM -
Measurement of Functional Outcome Using the Modified Rankin Scale in Patients With Acute Ischemic Stroke
Sep 9, 2025, 16:22 PM -
How Cost-Effectiveness and Budget Impact Drive Pricing and Reimbursement: Insights From an International Comparative Study
Sep 9, 2025, 16:22 PM -
Evaluating a Deep Learning Model for Classifying Pediatric Pneumonia in Israel
Sep 9, 2025, 16:22 PM -
Estimating Life-Years and QALYs Gained From Tumor Treating Fields in Newly Diagnosed Glioblastoma: A US-Based Real-World Survival-Based Model
Sep 9, 2025, 16:22 PM -
Five-Year Clinical and Economic Impact of 20 Weight Loss in Adults With Obesity in Saudi Arabia: A Public Healthcare Perspective
Sep 9, 2025, 16:22 PM -
Pegunigalsidase Alfa Elfabrio® as a Long-Term Enzyme Replacement Therapy in Adults With Fabry Disease: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
The Socioeconomic Value of Adult Respiratory Immunization Programs in Spain: How Much Can We Gain From Expanding Prevention Efforts?
Sep 9, 2025, 16:22 PM -
Analysis of the Epidemiological Disease Burden of Endometriosis in Hungary Based on Data From the Global Burden of Disease Study
Sep 9, 2025, 16:22 PM -
Long-Term Economic Impact of Nonpersistence to Disease-Modifying Therapies in a Cohort of German Patients With Multiple Sclerosis
Sep 9, 2025, 16:22 PM -
Organizational and Environmental Impact of Switching From Intravenous to Subcutaneous Immune Checkpoint Inhibitors (ICIs) in France: A Real-World Analysis Using PMSI Data
Sep 9, 2025, 16:22 PM -
NICE and CDA Assessment of Artificial Intelligence-Enabled Health Technologies: Analysis and Insights
Sep 9, 2025, 16:22 PM -
From Theory to Practice: Guidance for Identifying and Selecting Mapping Algorithms for Health Economic Models
Sep 9, 2025, 16:22 PM -
Bridging National and EU HTA Regulation: Policy Responses to the JCA Rollout
Sep 9, 2025, 16:22 PM
